MarketInOut Stock Screener Log In | Sign Up

Vetoquinol

PAR • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Vetoquinol stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangePAR
Market Capitalization940.43 mln
Float3.54 mln
Earnings Date09/10/2026

EPS

5.44
Strong

P / E

15.62
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.5
Borderline

Relative Strength

95 / 100
Top performer

Debt / Equity

0.02
Debt-free

Business Description

Founded in 1933 and based in Lure, France, Vetoquinol SA researches, produces, and markets health products for both farm animals and household pets across Europe, the Americas, and Asia Pacific. Its range covers a broad spectrum of animal health needs, from pain relief and skin care to heart and kidney treatments. The company operates as part of the Soparfin SCA group.

Key Fundamentals

EPS5.44
P/E15.62
ROE10.66
RPS45.71
ROIC14.66
ROA8.34
Interest Cover54.00
EBITDA, mln115
EV / EBITDA5.59
EV / EBIT7.72
Revenue, mln527
EV / Revenue1.22

Quote Details

Last 85.00
Change -3.5 (-3.95%)
Open 86.90
Volume 6,763
Turnover 574,855
Average Volume 7,224.67

Financial Ratios

Pre-Tax Profit Margin16
Leverage Ratio1.27
Current Ratio3.35
Price / Book1.45
Price / Tangible Book2.14
Price / Cash Flow9.45
Price / Free Cash Flow10.12
Debt / Equity0.02
Price / Sales1.67
PEG Ratio1.56

Financial Strength

Altman Z-Score4.53
Piotroski F-Score 7 / 9
Beneish M-Score-2.5
Price to Intrinsic Value0.71
Price to Lynch Fair Value1.74
Price to Graham Number1.14
Shiller PE Ratio19.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.65% 94 / 100   
1 Month 16.12% 98 / 100   
2 Months 16.76% 94 / 100   
6 Months 13.8% 91 / 100   
1 Year 16.73% 77 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog